Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement

GlobeNewswire 11 days ago

BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

GlobeNewswire October 22, 2024

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

GlobeNewswire July 31, 2024

BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024

GlobeNewswire July 25, 2024

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

GlobeNewswire June 10, 2024

BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire May 30, 2024

BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire May 30, 2024

BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

GlobeNewswire May 21, 2024

BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent  

GlobeNewswire May 3, 2024

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

GlobeNewswire April 30, 2024

BioSig Engages Consulting Firm for Business Model Strategies

GlobeNewswire April 4, 2024

BioSig Announces Reduction of its Workforce

GlobeNewswire February 20, 2024

BioSig's PURE EP(TM) Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases

GlobeNewswire February 6, 2024

BioSig Announces Reverse Stock Split

GlobeNewswire January 31, 2024

BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy

GlobeNewswire January 30, 2024

BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024

GlobeNewswire December 6, 2023

BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire November 13, 2023

BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire November 9, 2023

BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP

GlobeNewswire November 7, 2023

BioSig's New PURE EP(TM) Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care

GlobeNewswire November 2, 2023